LLY congressional trades
Eli Lilly and Company (LLY) appears in 66 congressional disclosure rows from 21 members of Congress in 2025–2026 periodic reports: 24 purchases and 42 sales, with trade dates from Oct 29, 2024 to Jul 10, 2026. Josh Gottheimer reported the most, with 13 rows. The median gap between trade date and filing date is 30 days, and 11 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live LLY portfolio or a trading signal.
- 66
- 21
- 24 / 42
- $382K – $1.7M
- sum of reported ranges
- 2026-07-10
Verified LLY congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 24 purchases and 42 sales. Reported owners: Spouse, Self, Joint. Transaction dates run from 2024-10-29 to 2026-07-10.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Dan Newhouse | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #20034998 Filed 2026-07-17 | |
| Michael Rulli | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20035147 Filed 2026-08-07 | |
| Gilbert Cisneros | Eli Lilly and Company Common Stock | Purchase | Self | $50,001 - $100,000 | #20034906 Filed 2026-07-02 | |
| Gilbert Cisneros | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20034500 Filed 2026-05-08 | |
| Lizzie Fletcher | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20034413 Filed 2026-05-01 | |
| Byron Donalds | Eli Lilly and Company Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20034478 Filed 2026-05-13 | |
| Byron Donalds | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20034478 Filed 2026-05-13 | |
| Alan Armstrong | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Gilbert Cisneros | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20034285 Filed 2026-04-07 | |
| David Taylor | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20034138 Filed 2026-03-06 | |
| Angus King | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #09b9c1ed-1d73-4f17-b6f8-7b2d92021c5b Filed 2026-03-24 | |
| David Taylor | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20034036 Filed 2026-02-20 | |
| David Taylor | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20033916 Filed 2026-02-02 | |
| Michael Rulli | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20035147 Filed 2026-08-07 | |
| Angus King | Eli Lilly and Company | Purchase | Spouse | $1,001 - $15,000 | #d7cae837-f73c-4eb1-b9fb-e510f53d65de Filed 2026-01-26 | |
| Julie Johnson | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20033789 Filed 2026-01-15 | |
| David Taylor | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20033666 Filed 2025-12-19 | |
| Michael Rulli | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20035147 Filed 2026-08-07 | |
| John Boozman | Eli Lilly and Company | Sale | Joint | $1,001 - $15,000 | #51455bcd-4966-4e77-b481-09897ada81ae Filed 2026-08-24 | |
| John Boozman | Eli Lilly and Company | Sale | Joint | $1,001 - $15,000 | #3a779539-8451-49d2-8419-d3eb72c7922a Filed 2025-12-08 | |
| Gilbert Cisneros | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20033619 Filed 2025-12-15 | |
| Julie Johnson | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20033611 Filed 2025-12-11 | |
| Shelley Capito | Eli Lilly and Company | Purchase | Spouse | $1,001 - $15,000 | #defd46d8-f9db-46d6-96f9-77bebce203b6 Filed 2025-11-04 | |
| Valerie Hoyle | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| John Boozman | Eli Lilly and Company | Purchase | Joint | $1,001 - $15,000 | #59bccfcc-9400-4d3d-917f-ce22a0fd2feb Filed 2025-09-12 | |
| Julie Johnson | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20032066 Filed 2025-09-11 | |
| David Taylor | Eli Lilly and Company Common Stock | Purchase | Self | $15,001 - $50,000 | #20030782 Filed 2025-09-02 | |
| David Taylor | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20030782 Filed 2025-09-02 | |
| John Boozman | Eli Lilly and Company | Purchase | Joint | $1,001 - $15,000 | #59bccfcc-9400-4d3d-917f-ce22a0fd2feb Filed 2025-09-12 | |
| Lisa McClain | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Eli Lilly and Company Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Jonathan Jackson | Eli Lilly and Company Common Stock | Sale | Joint | $15,001 - $50,000 | #20030599 Filed 2025-07-14 | |
| Gilbert Cisneros | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20030461 Filed 2025-06-06 | |
| Jonathan Jackson | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030860 Filed 2025-08-25 | |
| Marjorie Greene | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20030389 Filed 2025-05-19 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20030462 Filed 2025-06-11 | |
| Jefferson Shreve | Eli Lilly and Company Common Stock | Sale | Self | $100,001 - $250,000 | #20030387 Filed 2025-06-22 | |
| Valerie Hoyle | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 | |
| Marjorie Greene | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20030295 Filed 2025-05-06 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Purchase | Joint | $1,001 - $15,000 | #20030462 Filed 2025-06-11 | |
| Jonathan Jackson | Eli Lilly and Company Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030860 Filed 2025-08-25 | |
| Jonathan Jackson | Eli Lilly and Company Common Stock | Purchase | Joint | $15,001 - $50,000 | #20030283 Filed 2025-05-13 | |
| Bruce Westerman | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20030332 Filed 2025-05-12 | |
| Tommy Tuberville | Eli Lilly and Company | Sale | Joint | $15,001 - $50,000 | #014817f0-9809-457f-8ac5-048948608e02 Filed 2026-08-05 | |
| Tommy Tuberville | Eli Lilly and Company | Sale | Joint | $15,001 - $50,000 | #63e4a2b1-5bfc-43b6-b952-ba54e377212c Filed 2025-05-15 | |
| Dan Newhouse | Eli Lilly and Company Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030292 Filed 2025-05-16 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20030338 Filed 2025-05-14 | |
| Robert Bresnahan | Eli Lilly and Company Common Stock | Sale | Self | $1,001 - $15,000 | #20030238 Filed 2025-04-28 | |
| Julie Johnson | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20030296 Filed 2025-05-14 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20029083 Filed 2025-04-10 | |
| Bruce Westerman | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20030146 Filed 2025-04-16 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20027901 Filed 2025-03-06 | |
| Ron Wyden | Eli Lilly and Company Common Stock | Sale | Spouse | $50,001 - $100,000 | #f3e6926f-70d4-4265-9b81-68798dfc73bb Filed 2025-02-21 | |
| Ron Wyden | Eli Lilly and Company Common Stock | Purchase | Spouse | $50,001 - $100,000 | #f3e6926f-70d4-4265-9b81-68798dfc73bb Filed 2025-02-21 | |
| Marjorie Greene | Eli Lilly and Company Common Stock | Purchase | Self | $1,001 - $15,000 | #20026658 Filed 2025-01-27 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026732 Filed 2025-02-10 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Lisa McClain | Eli Lilly and Company Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Josh Gottheimer | Eli Lilly and Company Common Stock | Sale | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Valerie Hoyle | Eli Lilly and Company Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
LLY disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Josh Gottheimer's LLY trades | 13 | 1 | 12 | 2025-05-13 |
| David Taylor's LLY trades | 6 | 3 | 3 | 2026-02-26 |
| Gilbert Cisneros's LLY trades | 5 | 3 | 2 | 2026-06-10 |
| John Boozman's LLY trades | 4 | 2 | 2 | 2025-11-21 |
| Jonathan Jackson's LLY trades | 4 | 2 | 2 | 2025-06-03 |
| Julie Johnson's LLY trades | 4 | 0 | 4 | 2025-12-18 |
| Lisa McClain's LLY trades | 4 | 2 | 2 | 2025-07-16 |
| Marjorie Greene's LLY trades | 3 | 3 | 0 | 2025-05-14 |
| Michael Rulli's LLY trades | 3 | 1 | 2 | 2026-07-01 |
| Valerie Hoyle's LLY trades | 3 | 1 | 2 | 2025-09-23 |
| Angus King | 2 | 1 | 1 | 2026-02-13 |
| Bruce Westerman | 2 | 1 | 1 | 2025-04-21 |
| Byron Donalds | 2 | 2 | 0 | 2026-04-02 |
| Dan Newhouse | 2 | 0 | 2 | 2026-07-10 |
| Ron Wyden | 2 | 1 | 1 | 2025-02-10 |
| Tommy Tuberville | 2 | 0 | 2 | 2025-04-15 |
| Alan Armstrong | 1 | 0 | 1 | 2026-03-27 |
| Jefferson Shreve | 1 | 0 | 1 | 2025-05-12 |
| Lizzie Fletcher | 1 | 0 | 1 | 2026-04-08 |
| Robert Bresnahan | 1 | 0 | 1 | 2025-04-08 |
| Shelley Capito | 1 | 1 | 0 | 2025-10-24 |
How long disclosure took
Days from trade date to filing date for 66 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 11
- 16–30 days
- 24
- 31–45 days
- 20
- Over 45 days
- 11
- Median / longest
- 30d / 477d
Source documents
48 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #51455bcd-4966-4e77-b481-09897ada81aeFiled 2026-08-24 · 1 row
- #20035147Filed 2026-08-07 · 3 rows
- #014817f0-9809-457f-8ac5-048948608e02Filed 2026-08-05 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #20034998Filed 2026-07-17 · 1 row
- #20034906Filed 2026-07-02 · 1 row
- #20034478Filed 2026-05-13 · 2 rows
- #20034500Filed 2026-05-08 · 1 row
- #20034413Filed 2026-05-01 · 1 row
- #20034285Filed 2026-04-07 · 1 row
- #09b9c1ed-1d73-4f17-b6f8-7b2d92021c5bFiled 2026-03-24 · 1 row
- #20034138Filed 2026-03-06 · 1 row
36 older filings are linked from the transaction table.
What LLY filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Eli Lilly and Company financials and filings
Audited SEC figures, what moves LLY, and primary sources.
Compare ABBV vs LLY side by side
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
LLY congressional trades: FAQ
Who in Congress traded LLY?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 66 verified LLY rows from 21 members: Alan Armstrong, Angus King, Bruce Westerman, Byron Donalds, and 17 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current LLY holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are LLY amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $50,001 - $100,000; $15,001 - $50,000; $100,001 - $250,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is LLY congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (177 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded LLY.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-10-15. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported LLY and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included